01—Abstract
Summary
Summary of the 8-K filed October 7, 2024. Cited figures are marked; the original filing is the authoritative source.
West Pharmaceutical Services, Inc. (WST) filed a Current Report on Form 8-K dated October 1, 2024 under Item 5.02, disclosing that Silji Abraham, Senior Vice President & Chief Technology Officer, notified the Company on October 1, 2024 that he intends to resign effective December 31, 2024, to pursue other interests.
The filing states that the departure is not the result of any disagreement with the Company on matters related to operations, policies or practices. The Company stated it will work with Mr. Abraham and his leadership team to ensure a smooth transition of his duties before his departure. The filing also states that Mr. Abraham will receive no additional compensation as a result of his departure.
The filing contains no financial results, guidance, or financial statements. Its only Item 9.01 content is an Inline XBRL cover page (Exhibit 104), so the disclosure is limited to a senior executive leadership change with a defined effective date.
02—Key points
Key Highlights
- Silji Abraham, Senior Vice President & Chief Technology Officer, intends to resign effective December 31, 2024.
- Notice of resignation was given to the Company on October 1, 2024, to pursue other interests.
- The filing states the departure is not the result of any disagreement with the Company on operations, policies or practices.
- Mr. Abraham will receive no additional compensation as a result of his departure.
- The Company will work with Mr. Abraham and his leadership team to ensure a smooth transition of his duties before his departure.
- The filing contains no financial results, financial statements, or guidance.
- Item 9.01 lists only an Inline XBRL cover page (Exhibit 104) as an exhibit.
03—Questions
Frequently Asked Questions
Who is leaving West Pharmaceutical Services and in what role?
Silji Abraham, Senior Vice President & Chief Technology Officer, is leaving the Company. He notified the Company on October 1, 2024 that he intends to resign.
When will the departure take effect?
The resignation is effective December 31, 2024.
Why is the executive leaving?
The filing states Mr. Abraham intends to resign to pursue other interests. It also states the departure is not the result of any disagreement with the Company on matters related to operations, policies or practices.
Will the executive receive any severance or additional pay?
No. The filing states that Mr. Abraham will receive no additional compensation as a result of his departure.
How will the Company handle the transition of the CTO's responsibilities?
The Company stated it will work with Mr. Abraham and his leadership team to ensure a smooth transition of his duties prior to his departure.
04—Continue